Virus vectors and methods of making and administering the same

Details Virus vectors and methods of making and administering the same Virus vectors and methods of making and administering the same

2007-02-06

2007-02-06

Woitach, Joseph (Department: 1632)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

C435S005000, C435S239000, C435S471000, C424S093100

Reexamination Certificate

active

10205942

ABSTRACT:
The present invention provides genetically-engineered parvovirus capsids and viruses designed to introduce a heterologous gene into a target cell. The parvoviruses of the invention provide a repertoire of vectors with altered antigenic properties, packaging capabilities, and/or cellular tropisms as compared with current AAV vectors.

REFERENCES:
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5436146 (1995-07-01), Shenk et al.
patent: 5478745 (1995-12-01), Samulski et al.
patent: 5589377 (1996-12-01), Lebkowski et al.
patent: 5622856 (1997-04-01), Natsoulis
patent: 5658785 (1997-08-01), Johnson
patent: 5681731 (1997-10-01), Lebkowski et al.
patent: 5753500 (1998-05-01), Shenk et al.
patent: 5756283 (1998-05-01), Wilson et al.
patent: 5773289 (1998-06-01), Samulski et al.
patent: 5780280 (1998-07-01), Lebkowski et al.
patent: 5780447 (1998-07-01), Nienhuis
patent: 5786211 (1998-07-01), Johnson
patent: 5834441 (1998-11-01), Philip et al.
patent: 5843742 (1998-12-01), Natsoulis et al.
patent: 5846528 (1998-12-01), Podsakoff et al.
patent: 5846546 (1998-12-01), Hurwitz et al.
patent: 5856152 (1999-01-01), Wilson et al.
patent: 5858351 (1999-01-01), Podsakoff et al.
patent: 5858775 (1999-01-01), Johnson
patent: 5861171 (1999-01-01), Philip et al.
patent: 5861314 (1999-01-01), Philip et al.
patent: 5863541 (1999-01-01), Samulski et al.
patent: 5866552 (1999-02-01), Wilson et al.
patent: 5866696 (1999-02-01), Carter et al.
patent: 5869305 (1999-02-01), Samulski et al.
patent: 5871982 (1999-02-01), Wilson et al.
patent: 5872005 (1999-02-01), Wang et al.
patent: 5874304 (1999-02-01), Zolotukhin et al.
patent: 5874556 (1999-02-01), Lupton et al.
patent: 5882652 (1999-03-01), Valdes et al.
patent: 5905040 (1999-05-01), Mazzara et al.
patent: 5916563 (1999-06-01), Young et al.
patent: 5922315 (1999-07-01), Roy
patent: 5945335 (1999-08-01), Colosi
patent: 5952221 (1999-09-01), Kurtzman et al.
patent: 5962274 (1999-10-01), Parks
patent: 5962313 (1999-10-01), Podsakoff et al.
patent: 6001371 (1999-12-01), Young et al.
patent: 6156303 (2000-12-01), Russell et al.
patent: 6468524 (2002-10-01), Chiorini et al.
patent: 6491907 (2002-12-01), Rabinowitz et al.
patent: 6759237 (2004-07-01), Wilson et al.
patent: 2004/0057931 (2004-03-01), WIlson et al.
patent: 2004/0057932 (2004-03-01), Wilson et al.
patent: 2004/0057933 (2004-03-01), Wilson et al.
patent: 199942205 (2003-06-01), None
patent: WO 95/28493 (1995-10-01), None
patent: WO 96/00587 (1996-01-01), None
patent: WO 96/36364 (1996-11-01), None
patent: WO 97/05266 (1997-02-01), None
patent: WO 97/38423 (1997-10-01), None
patent: WO 98/09524 (1998-03-01), None
patent: WO 98/11244 (1998-03-01), None
patent: WO 98/32842 (1998-07-01), None
patent: WO 98/41240 (1998-09-01), None
patent: WO 99/61601 (1999-12-01), None
patent: WO 99/67393 (1999-12-01), None
patent: WO 00/28061 (2000-05-01), None
patent: WO 01/05991 (2001-01-01), None
patent: WO 01/05990 (2001-02-01), None
Horiuchi et al. J Gen Virol. Jun. 1994; 75 (Pt 6):1319-28, Mapping of determinants of the host range for canine cells in the genome of canine parvovirus using canine parvovirus/mink enteritis virus chimeric viruses.
Wang et al: J Virol. Mar. 1996; 70(3):1668-77. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral gen.
Srivastava et al. Proc. Natl Acad Sci U S A. Oct. 1989; 86(20):8078-82. Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in a AAV-B19 hybrid virus.
Bartlett et al. Viral Vectors, Chapter 4, pp. 55-73.
Chapman et al. Virology (1993) 194:491-508.
Brown et al. Virology (1994), 198:477-488.
Rabinowitz et al., “Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus,”Virology265:274-285 (1999).
Bloom et al., “Characterization of Chimeric Full-Length Molecular Clones of Aleutian Mink Disease Parvoviurs (ADV): Identification of a Determinant Governing Replication of ADV in Cell Culture,”Journal of Virology: 5976-5988 (Oct. 1993).
Spitzer et al., “Tropic determinant for canine parvovirus and feline panleukopenia virus functions through the capsid protein VP2,”Journal of General Virology78: 925-928 (1997).
Xiao et al., “Gene Therapy Vectors Based on Adeno-Associated Virus Type 1,”Journal of Virology73(5): 3994-4003 (May 1999).
Anderson, “Human Gene Therapy,”Nature392: 25-30 (1998).
Antonietti et al.; “Characterization of the Cell Type-Specific Determinant in the Genome of Minute Virus of Mice,”Journal of Virology62:2 552-557 (Feb. 1988).
Ball-Goodrich et al.; Two Amino Acid Substitutions within the Capsid Are Coordinately Required for Acquisition of Fibrotropism by the Lymphotropic Strain of Minute Virus of Mice,Journal of Virology66:6 3415-3423 (Jun. 1992).
Bartlett et al., “Genetics and Biology of Adeno-Associated Virus,”Viral Vectors55-73 (1995).
Bartlett et al.; Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2antibody,Nature Biotechnology17 181-191 (Feb. 1999).
Bloom et al.; Construction of Pathogenic Molecular Clones of Aleutian Mink Disease Parvovirus that Replicate Bothin Vivoandin Vitro, Virology251 288-296 (1998).
Brown et al.; Chimeric Parvovirus B19 Capsids for the Presentation of Foreign Epitopes,Virology198 477-488 (1994).
Brown et al.; Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus,Science262 114-117 (Oct. 1, 1993).
Chang et al.; Multiple Amino Acids in the Capsid Structure of Canine Parvovirus Coordinately Determine the Canine Host Range and Specific Antigenic and Hemagglutination Properties,Journal of Virology66:12 6858-6867 (Dec. 1992).
Chapman et al.;Structure, Sequence, and Function Correlation Among Parvoviruses, Virology 194:491-508 (1993).
Chiorini et al.; Adeno-Associated Virus (AAV) Type 5 Rep Protein Cleaves a Unique Terminal Resolution Site Compared with Other AAV Serotypes,Journal of Virology73:5 4293-4298 (May 1999).
Chiorini et al.; Cloning and Characterization of Adeno-Associated virus Type 5,Journal of Virology73:2 1309-1319 (Feb. 1999).
Chiorini et al.; Cloning of Adeno-Associated Virus Type 4 (AAV4) and Generation of Recombinant AAV4 Particles,Journal of Virology71:9 6823-6833 (Sep. 1997).
Fu et al., Viral sequences enable efficient and tissue-specific expression of transgenes inXenopus, Nature Biotechnology16 253-257 (Mar. 1998).
Gao et al.;High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle Virus, Human Gene Therapy 9:23253-2362 (Nov. 1, 1998).
Gardiner et al.; “Mapping of the Fibrotropic and Lymphotropic Host Range Determinants of the Parvovirus Minute Virus of Mice,”Journal of Virology62:8 2605-2613 (Aug. 1988).
Girod et al.; Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2,Nature Medicine5:9 1052-1056 (Sep. 1999).
Goldman et al.; Targeted Gene Delivery to Kaposi's Sarcoma Cellsviathe Fibroblast Growth Factor Receptor,Cancer Research57 1447-1451 (Apr. 15, 1997).
Hermonat et al.; Genetics of Adeno-Associated Virus: Isolation and Preliminary Characterization of Adeno-Associated Virus Type 2 Mutants,Journal of Virology51:2 329-339 (Aug. 1984).
Horiuchi et al.;Mapping of Determinants of the Host Range for Canine Cells in the Genome of Canine Parvovirus Using Canine Parvovirus/Mink Enteritis Virus Chimeric Viruses, Journal of General Virology 75:1319-1328 (1994).
International Search Report, PCT/US99/26505, Date of Mailing: Mar. 22, 2000.
Li et al.; Role for Highly RegulatedrepGene Expression in Adeno-Associated Virus Vector Production,Journal of Virology71:7 5236-5243 (Jul. 1997).
Maxwwell et al.; Targeting a Feline Parvovirus to Human Tumor Cells (abstract), Cold Spring Harbor Laboratory, Vector Targeting Strategies for Therapeutic Gene Delivery meeting (Mar. 11-14, 1999) p. 87.
Miyamura et al.; Parvovirus particles as plat

Affiliated with

Also associated with

Rating

Virus vectors and methods of making and administering the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Virus vectors and methods of making and administering the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virus vectors and methods of making and administering the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3834419